First leukemia patient dosed with SMART101
Smart Immune has announced that the first adult leukemia patient has been dosed with SMART101,…
Smart Immune has announced that the first adult leukemia patient has been dosed with SMART101,…
The Spanish Agency of Medicines and Medical Products (AEMPS) has approved the CARxALL clinical trial…
Patient-derived CAR-T immunotherapies have dominated the cancer immunotherapy space over the last decade. The EU…
A new case of blood cancer gets diagnosed approximately every three minutes in Western countries.…
Estrella Biopharma, Inc. and TradeUP Acquisition Corp. have entered into a definitive business combination agreement…
Scribe Therapeutics has entered into an agreement with Sanofi which will allow Sanofi use of…
Exploratory analysis of anti-cancer drug, navitoclax, combined with ruxolitinib - a medication for the treatment…
AstraZeneca announced today (July 5) it has agreed to buy a company working on a…
Chimeric antigen receptor (CAR) cell therapy offers hope where other cancer therapies have failed. However,…
Confidence in gene-edited T cell therapies from donor cells has faltered as Allogene Therapeutics paused…
CAR-T therapy has been hailed as a cure for cancer, but what really is this…
Update (01/02/2019): MorphoSys has agreed to end its long-running legal battle with Genmab and Janssen, after…